6th International Congress of Myology

25 – 28 March 2019

More than ever, therapeutic innovation will be at the heart of this event in all its aspects: gene therapy, pharmacogenomics, gene surgery and others.

The successful research conducted in nerve and muscle physiology, and in neuromuscular disorders in general, as well as the multiplication of clinical trials involving hundreds of patients worldwide are now bearing fruit. The first effective treatments are now available for patients, and ongoing trials are more than ever synonym of hope and victories to come. We know it, a new era is opening up for our diseases that were regarded as incurable till recently, and MYOLOGY 2019 will reflect this change of paradigm for sure.

Poster abstract submission deadline extended to 22nd October 2018

Early bird registration rate closes – 31st January 2019



Bordeaux-Lac Convention Centre
Avenue Jean Gabriel Domergue
33300 Bordeaux

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern